Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Pharmacology, Biochemistry, and Behavior|May 22, 2003
Norepinephrine regulates locomotor hyperactivity in the mouse mutant colobomaMichelle D Jones, Ellen J HessNeurobiology of Disease|February 13, 2007
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHDXueliang Fan, Ellen J HessRare Diseases (Austin, Tex.)|May 4, 2016
A commentary on the utility of a new L-DOPA-responsive dystonia mouse modelSamuel J Rose, Ellen J HessParkinsonism & Related Disorders|August 9, 2017
Evolving concepts in the pathogenesis of dystoniaH A Jinnah, Ellen J HessNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Experimental therapeutics for dystoniaH A Jinnah, Ellen J HessNeurobiology of Disease|July 15, 2006
The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorderKristy J Bruno, Ellen J HessNeurobiology of Disease|October 26, 2005
Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathyBrandy E Fureman, Ellen J HessMovement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Animal models for dystoniaBethany K Wilson, Ellen J HessNeurobiology of Disease|October 21, 2009
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDXueliang Fan, Ming Xu, Ellen J HessTremor and Other Hyperkinetic Movements (New York, N.Y.)|November 11, 2017
The Anatomical Basis for Dystonia: The Motor Network ModelH A Jinnah, Vladimir Neychev, Ellen J HessPageof 9